| Note: this medical device record is a supplement. The device description may have changed. Be sure to look at the original PMA to get an up-to-date view of this device. |
| |
| Trade Name | THERMOCOOL SF NAV UNI-DIRECTIONAL CATHETER (D-1315-XX-S, D-1318-XX-S) AND THERMOCOOL SF UNI-DIRECTIONAL CATHETER |
| Classification Name | catheter, percutaneous, cardiac ablation, for treatment of atrial fibrillation |
| Applicant | BIOSENSE WEBSTER, INC. |
| PMA Number | P030031 |
| Supplement Number | S034 |
| Date Received | 06/30/2011 |
| Decision Date | 12/21/2011 |
| Product Code | |
| Advisory Committee |
Cardiovascular |
| Supplement Type | normal 180 day track |
| Supplement Reason | change design/components/specifications - other |
| Expedited Review Granted? | No |
| Combination Product |
No
|
Approval Order Statement Approval for the following modifications: 1) reduced recommended saline flow rate (reduce by ~50%; 2) increase in number of irrigation holes (from 6 to 56); 3) decrease in size of irrigation holes (from 0. 016¿ to 0. 0035¿ diameter); and 4) modified tip electrode material (from 90% platinum/10% iridium to 80% palladium/20% platinum). The device, as modified will be marketed under the trade names uni-directional carto xp thermocool sf nav catheter, uni-directional carto 3 thermocool sf nav catheter, and uni-directional thermocool sf catheter and is indicated for catheter based cardiac electrophysiological mapping (stimulating and recording) and, when used with a compatible rt generator, for the treatment of: a) type i atrial flutter in patients age 18 or older; b) drug refractory recurrent symptomatic paroxysmal atrial fibrillation, when used with compatible three-dimensional electroanatomic mapping systems. The thermocool sf nav diagnostic/ablation deflectable tip catheter provides location information when used with compatible carto ep navigation ssytems. The biosense webster thermocool sf diagnostic/ablation deflectable tip catheter and related accessories are indicated for use in catheter-based cardiac electrophysiological mapping (stimulating and recording) and, when used with a compatible rf generator, for the treatment of type i atrial flutter in patients age 18 or older. |
|
|